… by which cells become multidrug resistant (MDR): by … in overcoming resistance of cancer
cells than co-treatment of cancer … -delivery systems in overcoming multidrug cancer resistance. …

… Crosstalk between several intracellular signaling pathways is one of the major reasons
for acquired resistance to targeted-therapy agents [139]. BCR and receptor tyrosine kinase-like …

… these agents on normal cells and from resistance – inherent or acquired – to therapeutic
agents… Combination chemotherapy was devised to overcome resistance, by treating with agents …

… Delivery of novel therapeutic agents in tumors: physiological barriers and rtrategier. JNCI 81,
570-576… Vascular and interstitial barriers to delivery of therapeutic agents in tumors. Concer …

… factor that limits the efficacy of a number of anticancer agents. … MCL1 for breast cancer to
overcome clinical resistance. … the focus of discovering novel therapeutic agents against the ABL …

… cancer leads to the distinguishing of several potential therapeutic agents for can cancer …
The key causes for cancer therapy failure are multidrug resistance, which happened at the …

… resistance to different therapeutic agents. Overexpression of miR-1, miR-125a, miR-150, and
miR-425 in glioblastoma increased the resistance of … preventing therapeutic resistance [56]. …

… In this review, we briefly describe the role of MUC1 proto-oncogene in cancer cell’s survival,
… which MUC1 induce resistance to various currently existing therapeutic agents in market …

… These novel anticancer agents are critically discussed by the authors, and therefore, the …
opportunities to combat cancers resistant to the established proapoptotic therapeutic agents. …

… resistance to cancer therapies, we from literature identified treatment-naïve epithelial cancer
… lines) that were rendered resistant to a cancer treatment (hereafter referred to as treatment-…